PULM logo

PULM
Pulmatrix Inc

20,378
Mkt Cap
$4.93M
Volume
5,653.00
52W High
$9.37
52W Low
$1.16
PE Ratio
-0.96
PULM Fundamentals
Price
$1.35
Prev Close
$1.40
Open
$1.38
50D MA
$1.94
Beta
0.40
Avg. Volume
95,283.39
EPS (Annual)
-$1.41
P/B
1.29
Rev/Employee
$0.00
$4.06
Loading...
Loading...
News
all
press releases
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger PR Newswire FRAMINGHAM...
PR Newswire·5d ago
News Placeholder
More News
News Placeholder
PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Pulmatrix, Inc. (NASDAQ: PULM) and Eos SENOLYTIX, Inc. Upon closing of the proposed transaction, Pulmatrix stockholders...
Business Wire·13d ago
News Placeholder
Pulmatrix To Acquire Eos Senolytix In Merger
(RTTNews) - Pulmatrix Inc. (PULM), a clinical-stage biopharmaceutical company, on Thursday announced that it has entered into a definitive agreement to acquire Eos Senolytix Inc. in a merger...
Nasdaq News: Markets·1mo ago
News Placeholder
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PR Newswire FRAMINGHAM, Mass. and HOUSTON, March 26, 2026...
PR Newswire·1mo ago
News Placeholder
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead
Pulmatrix said that Cullgen notified it of the termination of the deal between them on Feb. 28.
Stocktwits·2mo ago
News Placeholder
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of...
PR Newswire·2mo ago
News Placeholder
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results PR Newswire FRAMINGHAM, Mass., Feb. 26, 2026 Plans to...
PR Newswire·2mo ago
News Placeholder
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for...
PR Newswire·6mo ago
<
...
1
>

Latest PULM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.